Durable Responses from Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-CHOP) As First Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL): The Accept Phase Ib/II Single Arm Study

被引：2

作者：

Davies, Andrew J. ^{[1
,2
]}

Caddy, Josh ^{[3
]}

McLaughlin, Katy ^{[3
]}

Wignall, Christopher ^{[3
]}

Waugh, Robert ^{[3
]}

Collins, Graham P. ^{[4
]}

Stanton, Louise ^{[3
]}

Saunders, Geoff N. ^{[3
]}

Cummin, Thomas ^{[5
]}

Schuh, Anna ^{[6
]}

Ardeshna, Kirit M. ^{[7
]}

McMillan, Andrew K. ^{[8
]}

Radford, John ^{[9
,10
]}

Lewis, David John ^{[11
]}

Coleman, Adam R. ^{[1
]}

Griffiths, Gareth ^{[3
]}

Burton, Cathy ^{[12
]}

Barrans, Sharon ^{[12
]}

Johnson, Peter ^{[1
,13
]}

机构：

[1] Canc Res UK Expt Canc Med Ctr UK, Southampton, Hants, England

[2] Southampton Canc Res UK Ctr, Southampton, Hants, England

[3] Univ Southampton, Canc Res UK Southampton Clin Trials Unit, Southampton, Hants, England

[4] Churchill Hosp, Oxford Canc & Haematol Ctr, Oxford, England

[5] Portsmouth Hosp Univ NHS Trust, Portsmouth, Hants, England

[6] Univ Oxford, Oxford Mol Diagnost Ctr, Oxford, England

[7] Univ Coll London Hosp NHS Fdn Trust, Dept Haematol, London, England

[8] Nottingham Univ Hosp NHS Trust, Nottingham, England

[9] Univ Manchester, NIHR Clin Res Facil, Manchester, Lancs, England

[10] Christie NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England

[11] Derriford Hosp, Dept Haematol, Plymouth, Devon, England

[12] Leeds Canc Ctr, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England

[13] Univ Southampton, Fac Med, Sch Canc Sci, Southampton, Hants, England

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-163499

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9478 / 9479

页数：2

共 50 条

[21] Intratumoral T-cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B-cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R-CHOP) chemoimmunotherapy
Shanavas, Mohamed
Law, Soi-Cheng
Hertzberg, Mark
Hicks, Rodney J.
Seymour, John F.
Li, Zhixiu
Merida de Long, Lilia
Nath, Karthik
Sabdia, Muhammed B.
Gunawardana, Jay
Gandhi, Maher K.
Keane, Colm
CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (11)
[22] Health-Related Quality of Life (HRQoL) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) in the Phase III POLARIX Study
Friedberg, Jonathan W.
Thompson, Carrie A.
Trneny, Marek
Morschhauser, Franck
Salles, Gilles
Reagan, Patrick M.
Hertzberg, Mark
Smolewski, Piotr
Zhang, Huilai
Thieblemont, Catherine
Hu, Bei
Fonseca, Gustavo
Kim, Won-Seog
Martelli, Maurizio
Mehta, Amitkumar
Campinha-Bacote, Avrita
Yan, Mark
Hirata, Jamie
Sugidono, Matthew
Lee, Calvin
Sharman, Jeff P.
BLOOD, 2022, 140 : 6623 - 6626
[23] Expression of CD40 is a positive prognostic factor of diffuse large B-cell lymphoma treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)
Song, Guoqi
Ni, Huiyun
Zou, Linqing
Wang, Shukui
Tian, Fuliang
Liu, Hong
Cho, William C.
ONCOTARGETS AND THERAPY, 2016, 9 : 3799 - 3805
[24] Phase II trial of split-dose R-CHOP for older patients with diffuse large B-cell lymphoma (DLBCL)
Shah, Nirav Niranjan
Szabo, Aniko
Rajguru, Saurabh
Devata, Sumana
Howard, Mitch
Pereira, Deepa
Endres, Mariah
Longo, Walter L.
Hamadani, Mehdi
Fenske, Timothy S.
Fletcher, Christopher David
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[25] Phase II study of the tetrahydropyranyl adriamycin--cyclophosphamide, vincristine, and prednisolone regimen combined with rituximab as first-line treatment for elderly patients with diffuse large B-cell lymphoma
Kasahara, Senji
Hara, Takeshi
Tsurumi, Hisashi
Goto, Naoe
Kitagawa, Jun-Ichi
Kanemura, Nobuhiro
Yoshikawa, Takeshi
Goto, Hideko
Fukuno, Kenji
Yamada, Toshiki
Sawada, Michio
Takahashi, Takeshi
Takami, Tsuyoshi
Moriwaki, Hisataka
LEUKEMIA & LYMPHOMA, 2011, 52 (04) : 629 - 634
[26] A phase II study of rituximab combined with pirarubicin-cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma
Tsurumi, Hisashi
Hara, Takeshi
Goto, Naoe
Kitagawa, Jun-Ichi
Kanemura, Nobuhiro
Yoshikawa, Takeshi
Kasahara, Senji
Goto, Hideko
Fukuno, Kenji
Yamada, Toshiki
Sawada, Michio
Shimizu, Masahito
Takahashi, Takeshi
Takami, Tsuyoshi
Moriwaki, Hisataka
LEUKEMIA & LYMPHOMA, 2012, 53 (02) : 247 - 253
[27] Phase Ib study combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL)
Younes, Anas
Flinn, Ian
Berdeja, Jesus G.
Friedberg, Jonathan W.
Alberti, Sara
Thieblemont, Catherine
Morschhauser, Franck
Hellemans, Peter
Hall, Brett
Smit, Johan
Skee, Donna
de Vries, Ronald
Todorovic, Marija
Khan, Imran
Fourneau, Nele
Oki, Yasuhiro
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[28] Phase II Trial of Standard Dose Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) and Rituximab (R-CHOP) Plus Bevacizumab for Advanced Stage Diffuse Large B-Cell (DLBCL) NHL: Southwest Oncology Group Study S0515
Stopeck, Alison T.
Unger, Joseph M.
Rimsza, Lisa M.
Farnsworth, Brent
LeBlanc, Michael
Iannone, Maria
Fisher, Richard I.
Miller, Thomas P.
BLOOD, 2010, 116 (21) : 260 - 261
[29] Rituximab in Combination with Cyclophosphamide, Mitoxantrone, Vincristine and Prednisone (R-CNOP) As First Line Regimen in Elderly Patients with Diffuse Large B-Cell Lymphoma
Aslan, Alma
Turker, Alev
Kars, Ayse
Barista, Ibrahim
Ozdemir, Evren
BLOOD, 2016, 128 (22)
[30] RANDOMIZED PHASE II STUDY OF R-CHOP PLUS ENZASTAURIN VERSUS R-CHOP IN THE FIRST-LINE TREATMENT OF PATIENTS WITH INTERMEDIATE AND HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) - PRELIMINARY ANALYSIS
Hainsworth, J. D.
Arrowsmith, E. R.
Mccleod, M.
Fayad, L. E.
Hamid, O.
Davis, L.
Lin, B.
ANNALS OF ONCOLOGY, 2011, 22 : 107 - 107

← 1 2 3 4 5 →